Catherine Lacavera
Chief Legal Officer @ Turing
San Francisco Bay Area, United States
Catherine Lacavera is a seed investor at Turing in San Francisco Bay Area focused on Medical and Robotics. Catherine Lacavera is based out of Mountain View, California and is the Chief Legal Officer of Turing and Board of Directors at Toborlife AI. Catherine previously worked at ShipBob as Chief Legal Officer. Catherine Lacavera attended the University of Toronto. Catherine Lacavera has been awarded the Vanguard Award.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Catherine Lacavera invests in
Stages Catherine Lacavera invests in
Countries Catherine Lacavera invests in
Investment Focus
Industry
- Medical 1 (33%)
- Robotics 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Manufacturing 1 (33%)
Stage
- Seed 2 (67%)
- Pre-Seed 1 (33%)
Country
- Canada 1 (33%)
- Australia 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Skritswap
|
skritswap has AI technology that enables anyone to understand anything regardless of complexity. | $481K / Pre-Seed / Sep 07, 2018 | |
HealthMatch
|
HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets. | $1.3M / Seed / Jun 18, 2018 | |
Toborlife AI
|
Toborlife AI creates self-governing robot control systems. We collaborate with Unitree to provide high-performing, reasonably priced robotic systems for both commercial and residential clients. | Seed |
Co-Investors
About Turing
Turing.com connects world-class remote software engineers with world-class companies. 200+ companies, including those backed by Google Ventures, Andreessen, Founders Fund, Kleiner, and Bloomberg, have hired Turing developers. Over 1M+ developers from across 150+ countries have chosen Turing as their preferred platform for landing remote jobs.
Turing Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Catherine Lacavera
Chief Legal Officer
|
|||
Jonathan Siddharth
Founder and CEO
|
|||
Paula Griffin
Director of Product Management
|
|||
Alex Sung
Senior Product Manager
|
|||
Chul Kwon
Senior Product Manager
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Catherine Lacavera invest in?
Catherine Lacavera invests primarily in Medical, Robotics and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Catherine Lacavera last invest?
The most recent investment recorded for Catherine Lacavera closed in Sep 2018. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
